1st Quarter - Report

ASCENSION HEALTH ALLIANCE D/B/A ASCENSION for ASCENSION HEALTH ALLIANCE D/B/A ASCENSION

Firm
Client
Income
—
Expenses
$340,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Religion REL

Religious freedom and conscience protection.

LobbyistCovered position, as disclosed
MARK HAYES —
BROCK INGMIRE —
PETER LEIBOLD —
DANIELLE WHITE —

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Drug Enforcement Administration (DEA); SENATE; Vice President of the U.S.

Pharmacy PHA

Affordable prescription drugs, 340B program, drug shortages

LobbyistCovered position, as disclosed
MARK HAYES —
BROCK INGMIRE —
PETER LEIBOLD —
JOSEPH LUSTIG New —
DANIELLE WHITE —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Veterans Affairs, Dept of (VA); Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); Health & Human Services, Dept of (HHS); SENATE; Vice President of the U.S.

Health Issues HCR

Affordable prescription drugs, 340B Program, HR985 FAST Generics Act of 2019, Appropriate and accurate payment for healthcare, Site Neutral payment policies, S. 1895 - Lower Health Care Costs Act, S. 340 - CREATES Act, H.R. 987 - Strengthening Health Care and Lowering Prescription Drug Costs Act, S. 1391 - Fair Accountability and Innovative Research Drug Pricing Act of 2019, Surprise billing: S. 1531 - Stop the Outrageous Practice of Surprise Medical Bills Act of 2019; HR 3, the Lower Drug Costs Now Act; H.R.2149 - Exposing the Financing of Human Trafficking Act; H.R.508 - Trafficking Victims Housing Act of 2019; H.R. 1520 - Purple Book Continuity At of 2019; H.R. 1503 - Orange Book Transparency Act of 2019; S.2543 - Prescription Drug Pricing Reduction Act of 2019; Health care privacy; H.R. 647, S.2080 - Palliative Care and Hospice Education and Training Act; Conrad 30 and the Physician Access Reauthorization Act, S 948; Issues related to the Medicaid Fiscal Accountability Regulation (MFAR); HR 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act; HR 6201 - Families First Coronavirus Response Act; HR 748 - Coronavirus Aid, Relief, and Economic Security (CARES) Act; response to the COVID-19 public health emergency

LobbyistCovered position, as disclosed
MARK HAYES —
BROCK INGMIRE —
PETER LEIBOLD —
JOSEPH LUSTIG New —
DANIELLE WHITE —

Contacted: Office of Management & Budget (OMB); SENATE; Vice President of the U.S.; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); Food & Drug Administration (FDA)

Bills named: S. 1531 (116th), S. 1391 (116th), H.R. 6201 (116th), S. 1895 (116th), S. 340 (116th), H.R. 508 (116th), S. 2080 (116th), H.R. 748 (116th), S. 2543 (116th), H.R. 6074 (116th), H.R. 3 (116th), H.R. 985 (116th), H.R. 2149 (116th), H.R. 1503 (116th), H.R. 1520 (116th), H.R. 987 (116th), H.R. 647 (116th)

Veterans VET

Implementation of the Mission Act

LobbyistCovered position, as disclosed
MARK HAYES —
BROCK INGMIRE —
PETER LEIBOLD —
JOSEPH LUSTIG New —
DANIELLE WHITE —

Contacted: Veterans Affairs, Dept of (VA); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Vice President of the U.S.; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE

Medicare/Medicaid MMM

Site Neutral payment policies, Medicare for All, Medicare Buy In, Affordable prescription drugs, Medicaid DSH, Medicare bad debt, wage index, modernization of the Stark Law and Anti-Kickback statutes; H.R. 3 - Lower Drug Costs Now Act of 2019; S.2543 - Prescription Drug Pricing Reduction Act of 2019; Issues related to the Medicaid Fiscal Accountability Regulation (MFAR); HR 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act; HR 6201 - Families First Coronavirus Response Act; HR 748 - Coronavirus Aid, Relief, and Economic Security (CARES) Act; response to the COVID-19 public health emergency

LobbyistCovered position, as disclosed
MARK HAYES —
BROCK INGMIRE —
PETER LEIBOLD —
JOSEPH LUSTIG New —
DANIELLE WHITE —

Contacted: Veterans Affairs, Dept of (VA); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); SENATE; Health & Human Services, Dept of (HHS); Vice President of the U.S.

Bills named: H.R. 6074 (116th), S. 2543 (116th), H.R. 3 (116th), H.R. 748 (116th), H.R. 6201 (116th)

Immigration IMM

Supported maintaining the current definition of Public Charge to ensure continued access to Medicaid and other federal assistance programs; Conrad 30 and the Physician Access Reauthorization Act, S 948

LobbyistCovered position, as disclosed
MARK HAYES —
BROCK INGMIRE —
PETER LEIBOLD —
JOSEPH LUSTIG New —
DANIELLE WHITE —

Contacted: Food & Drug Administration (FDA); Office of Management & Budget (OMB); SENATE; Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Vice President of the U.S.; Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.